Medow Health AI Raises AUD 3.5M Seed to Automate Specialist Medical Reports

Medow Health AI Secures AUD 3.5 Million Seed Round

Medow Health AI, an Australian developer of artificial intelligence systems for medical documentation, has raised AUD 3.5 million in seed funding. The round was backed by investors Michael Boyer and Michael Solomon.

What the Company Does

Medow Health AI builds AI systems that automate medical reports for specialist doctors. Rather than requiring clinicians to dictate or manually draft documentation after patient encounters, the company's technology is designed to generate reports automatically as part of the clinical workflow.

A key element of the company's approach is integration. Medow Health AI's technology connects with medical practice management software, positioning it inside the systems that clinics already use for scheduling, records, and billing rather than as a standalone tool. That integration strategy is central to adoption, since it reduces the operational friction of adding a new documentation layer to an existing practice.

Traction Across Australia and New Zealand

According to the company, its technology is used by clinics in Australia and New Zealand. That cross-border footprint gives Medow Health AI a presence in two adjacent healthcare markets with comparable clinical and regulatory environments, and provides a reference base for further expansion in the region.

Funding Details

• Round type: Seed
• Amount raised: AUD 3,500,000
• Announced: September 16, 2026
• Investors: Michael Boyer, Michael Solomon

No lead investor was designated for the round.

Why This Round Matters

Medical documentation is one of the most persistent administrative burdens in specialist practice. For specialists in particular, report writing is both time-consuming and highly structured, which makes it a natural target for automation. Medow Health AI's focus on specialist reporting, rather than general-purpose clinical notes, narrows the problem it is solving and aligns the product with a defined user group.

The seed funding gives the company capital to deepen its integration with practice management software and to extend its clinic footprint across Australia and New Zealand. For acquirers and strategic partners in health technology, the round marks Medow Health AI as an early-stage asset with a working product, an established regional user base, and a distribution model built on embedding into existing clinical infrastructure.

Acquisition Perspective

Companies operating at the intersection of clinical workflow and AI documentation are attractive to larger healthcare IT platforms, practice management vendors, and revenue-cycle management providers looking to add automation to their stacks. Medow Health AI's integration-first design means its technology is already positioned to plug into the software layer that such acquirers typically control.

Its dual-market presence in Australia and New Zealand offers a regional beachhead, while the specialist-reporting niche provides a differentiated technical focus relative to broader ambient documentation tools. The seed round, backed by individual investors, keeps the cap table simple at this stage.

What to Watch

• Expansion of the clinic base beyond the current Australia and New Zealand footprint
• Deeper integrations with medical practice management software vendors
• Product development aimed at additional specialist reporting use cases
• Follow-on financing and the potential introduction of institutional investors

Medow Health AI's AUD 3.5 million seed round provides the runway to build on its existing clinic deployments and to strengthen its position in the specialist medical documentation market.